Targeting Eph receptors with peptides and small molecules: Progress and challenges
- 29 February 2012
- journal article
- review article
- Published by Elsevier BV in Seminars in Cell & Developmental Biology
- Vol. 23 (1), 51-57
- https://doi.org/10.1016/j.semcdb.2011.10.023
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenograftsBiomaterials, 2011
- Reversing EphB2 depletion rescues cognitive functions in Alzheimer modelNature, 2010
- The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesisAngiogenesis, 2010
- Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 ReceptorBiochemistry, 2010
- Can self‐inhibitory peptides be derived from the interfaces of globular protein–protein interactions?Proteins: Structure, Function, and Bioinformatics, 2010
- Structure–activity relationship study of EphB3 receptor tyrosine kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Discovery and structural analysis of Eph receptor tyrosine kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Peptide-Functionalized Nanogels for Targeted siRNA DeliveryBioconjugate Chemistry, 2009
- Eph-Ephrin Bidirectional Signaling in Physiology and DiseaseCell, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007